A carregar...

FDA Approvals of Brand-Name Prescription Drugs in 2015

I. New Pharmaceuticals: New Molecular Entities and New Biologic License Applications. II. New Combinations and New Indications. III. New Dosage Forms and New Formulations. IV. New Biosimilars, Vaccines, Viral Therapies, and Blood Products.

Na minha lista:
Detalhes bibliográficos
Publicado no:Am Health Drug Benefits
Formato: Artigo
Idioma:Inglês
Publicado em: Engage Healthcare Communications, LLC 2016
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5013848/
https://ncbi.nlm.nih.gov/pubmed/27668042
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!